ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,154 | -44.6% | 30,559 | -46.3% | 0.01% | -40.0% |
| Q2 2023 | $1,131,080 | +146.5% | 56,924 | +112.5% | 0.02% | +114.3% |
| Q1 2023 | $458,947 | -2.9% | 26,792 | +10.9% | 0.01% | -12.5% |
| Q4 2022 | $472,674 | +66.4% | 24,153 | +35.8% | 0.01% | +60.0% |
| Q3 2022 | $284,000 | +27.4% | 17,792 | +9.9% | 0.01% | +25.0% |
| Q2 2022 | $223,000 | -13.2% | 16,188 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $257,000 | – | 16,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |